The opening salvos have been fired in a €2.5 billion Irish court battle between some of the world’s largest aircraft lessors and their insurers over around 80 jets stranded in Russia. Dublin’s High Court earlier this month began to hear the case that lawyers involved expect to take many months. Here are the main arguments […]
Zombie Army In what stands to be a major cybersecurity win for US law enforcement, the Department of Justice announced the arrest of Yunhe Wan — a 35-year-old Chinese national accused of perpetrating what the FBI says is likely the biggest botnet scheme in history. According to a DOJ press release, officials allege that Wan […]
DETROIT (AP) — A second shareholder advisory firm has come out against reinstating a pay package for Tesla CEO Elon Musk that was voided earlier this year by a Delaware judge. ISS late Thursday joined Glass Lewis in recommending against the package, recently valued by the company at $44.9 billion but in January had a […]
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions Thursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion, an increase of 5% year-over-year, or 6% when adjusted for foreign exchange impacts, primarily driven by Eliquis, Reblozyl, and Opdualag, partially offset by Opdivo and Revlimid. Growth Portfolio […]
Rishi Sunak is making a surprise visit to Ukraine to meet Volodymyr Zelenskiy, as the UK announced it will provide £2.5 billion (€2.9 billion) in military aid to the country over the coming year. It comes as the Ukrainian president presses allies in the West to provide the country with more support to fight back […]
Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the promising heart-drug developer. The biotech company, currently running a sale process, leaves room for speculation on whether Novartis or another suitor might re-emerge or if the company will explore alternative options such as a […]